Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
05/15/1992 | WO1992008718A1 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
05/15/1992 | CA2094246A1 4-(1,2-benzisoxazolyl) piperidine antipsychotic agents |
05/15/1992 | CA2055326A1 N-benzoylproline derivatives, a process for their preparation and pharmaceutical compositions holding same |
05/15/1992 | CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them |
05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
05/14/1992 | WO1992007832A2 Substituted piperazines as central nervous system agents |
05/14/1992 | WO1992007831A1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
05/14/1992 | WO1992007564A2 Method of treating demyelinating disease |
05/14/1992 | WO1991016903A3 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
05/14/1992 | DE4035682A1 Lokalanaesthetikum Local anesthetic |
05/14/1992 | CA2055094A1 Cholecystokinin antagonist |
05/13/1992 | EP0485173A2 Esters and amides of substituted fused ring phenyl acetic acids |
05/13/1992 | EP0485026A2 Antimanic phenoxymethylene bisphosphonate derivatives |
05/13/1992 | EP0484719A2 Tachykinin antagonist |
05/13/1992 | EP0484660A1 Novel 5-(Phenoxyalcanoylamino)-uraciles, methodes for preparing them and their use as medicaments |
05/13/1992 | EP0484573A1 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
05/13/1992 | EP0484497A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders |
05/13/1992 | EP0484416A1 Regulation of nerve growth factor synthesis in the central nervous system |
05/12/1992 | US5112988 Intermediates for Substance P Antagonists |
05/12/1992 | US5112986 Chemical intermediates for analgesics |
05/12/1992 | US5112972 Cardiovascular disorders as hypotensive agents, angina pectoris |
05/12/1992 | US5112872 Antispasmodic agent |
05/12/1992 | US5112863 Antipsychotic drug |
05/12/1992 | US5112842 Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole |
05/12/1992 | US5112841 Imidazole derivatives and antiepileptics comprising said imidazole derivatives as effective ingredients |
05/12/1992 | US5112839 Treatment of Cardiac Insufficiency, Angina, Arrhythmia, Hypertension |
05/12/1992 | US5112838 Treatment of schizophrenia |
05/12/1992 | US5112826 Cardiovascular disorders |
05/12/1992 | US5112810 Nonapeptides for thymic factor and multiple sclerosis treatment |
05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
05/12/1992 | CA1300630C 8-piperazinyl-1, 7-naphthyridine derivative |
05/12/1992 | CA1300624C 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation and medicaments containing them |
05/10/1992 | WO1992008684A1 Local anaesthetic |
05/10/1992 | CA2096027A1 Local anesthetic |
05/09/1992 | CA2054520A1 Antimanic phenoxymethylene bisphosphonate derivatives |
05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
05/06/1992 | EP0484204A1 7-Cycloalkylimidazodiazepines and their salts, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them |
05/06/1992 | EP0484186A1 Formulations and their use in the treatment of neurological diseases |
05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
05/06/1992 | EP0484007A1 DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]-butyl]-1,8,8-trimethyl-3-azabicyclo[3,2,1]octane-2,4-dione having psychotropic and antiemetic effect |
05/06/1992 | EP0483881A1 3-Amidoindolyl derivatives |
05/06/1992 | EP0483854A1 Fatty emulsion |
05/06/1992 | EP0483633A1 8-Azabicyclo[3.2.1]octylalkylthiazolidinones, a process for their preparation and their use as medicaments |
05/06/1992 | EP0483580A2 1-(2-Arylethyl)-pyrrolidine |
05/06/1992 | EP0453515A4 Composition and method for treatment of senile dementia |
05/06/1992 | CN1060841A Quinazol derivatives and there preparation |
05/06/1992 | CN1060838A 5h-benzodiazepine derivatives, pharmaceutical compositions containing same and process for preparing them |
05/05/1992 | US5110828 Azabicyclo oxime derivatives |
05/05/1992 | US5110824 Method of treating disorders of cognitive function with substituted benzamides |
05/05/1992 | US5110823 Cognition activators |
05/05/1992 | US5110820 Hypotensive agents; cardiovascular disorders |
05/05/1992 | US5110815 Alzheimer's disease |
05/05/1992 | US5110797 Neurotropic agents |
05/05/1992 | CA1300161C Carboxamido dihydrobenzofuran and chroman derivatives, their preparation process and their use as neuroleptics |
05/05/1992 | CA1300157C Dihydropyridine compounds having unique pharmacological effects, and the process for producing them |
05/05/1992 | CA1300152C Diacylderivatives of glycerylphosphorylcholine having therapeutical activity, a process for their preparation and related pharmaceutical compositions |
05/05/1992 | CA1300149C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo-(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300148C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo(3,4-c)-pyridine derivatives |
05/05/1992 | CA1300139C Piperazinyl-heterocyclic compounds |
05/05/1992 | CA1300138C Oxabicycloheptane derivatives |
05/03/1992 | CA2054667A1 Cyclopeptides |
05/03/1992 | CA2054648A1 1-(2-arylethyl)-pyrrolidines |
05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
05/01/1992 | WO1992007853A1 Certain imidazoquinoxalines; a new class of gaba brain receptor ligands |
05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
04/30/1992 | WO1992006975A1 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
04/30/1992 | WO1992006974A1 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
04/30/1992 | WO1992006973A1 Indole derivatives |
04/30/1992 | WO1992006967A1 Therapeutically useful 2-aminotetralin derivatives |
04/30/1992 | WO1992006960A1 Piperazine derivatives |
04/30/1992 | WO1992006957A1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
04/30/1992 | WO1992006688A1 New medical use for a certain indole derivative and pharmaceutical composition containing it |
04/30/1992 | CA2093527A1 New medical use for a certain indole derivative and pharmaceutical composition containing it |
04/30/1992 | CA2071940A1 Piperazine derivatives |
04/29/1992 | EP0483063A1 Ergoline derivatives |
04/29/1992 | EP0482939A1 Isoquinolinone derivative |
04/29/1992 | EP0482696A1 4-[4- or 6-(Trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams |
04/29/1992 | EP0482493A2 Pharmaceutical compositions active in the therapy of neurological affections in aids patients, containing as an active principle at last one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid, 5-formyltetrahydrofolic acid |
04/29/1992 | EP0482084A1 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives. |
04/29/1992 | CN1016420B Dihydrobenzofuran-and chromancarboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics |
04/28/1992 | US5109011 Analgesics |
04/28/1992 | US5109008 Pharmaceutically useful furo[3,2-c]pyridines |
04/28/1992 | US5109006 Certain pharmaceutically active 6H-imidazo[1,2-a]pyridine-5-ones |
04/28/1992 | US5109002 Antipsychotic 1-cycloalkylpiperidines |
04/28/1992 | US5109001 Treating hyperactivity of excitatory neurotransmitters |
04/28/1992 | US5108363 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
04/28/1992 | CA1299579C2 Benzamides, preparation process and therapeutic use |
04/28/1992 | CA1299578C Indane derivatives, their preparation process and novel intermediates thus obtained, their application as medicines and compositions containing same |
04/28/1992 | CA1299571C 2-aminoacetamide pyridinyl derivatives |
04/27/1992 | CA2054225A1 8-azabicyclo[3.2.1] octylalkylthiazolidinones, a process for their preparation and their use as medicaments |
04/25/1992 | CA2054091A1 Isoquinolinone derivatives |
04/25/1992 | CA2054034A1 7-cycloalkylimidazodiazepines and the salts thereof; process for preparing the same and intermediates produced; their use as drugs; pharmaceutical compositions containing them |
04/24/1992 | WO1992006958A1 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist |
04/24/1992 | CA2072598A1 Pharmaceutical compositions |
04/24/1992 | CA2053980A1 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams |
04/23/1992 | CA2053772A1 Benzolactam analogs as antagonists of cck |
04/22/1992 | EP0481853A1 1-(3,4-Dihydro-2-oxo-1H-quinoline-6-yl)-2-[4-(2-phenylethyl)-piperidin-1-yl]ethanol and -ethane, their preparation and their use in therapeutics |
04/22/1992 | EP0481744A1 Piperazine derivatives |